240 related articles for article (PubMed ID: 29433569)
1. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
[TBL] [Abstract][Full Text] [Related]
2. MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.
Pohland M; Hagl S; Pellowska M; Wurglics M; Schubert-Zsilavecz M; Eckert GP
Neurochem Res; 2016 Feb; 41(1-2):231-42. PubMed ID: 26721513
[TBL] [Abstract][Full Text] [Related]
3. Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease.
Eckert GP; Eckert SH; Eckmann J; Hagl S; Muller WE; Friedland K
Exp Neurol; 2020 Jul; 329():113286. PubMed ID: 32199815
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
Robinson A; Grösgen S; Mett J; Zimmer VC; Haupenthal VJ; Hundsdörfer B; Stahlmann CP; Slobodskoy Y; Müller UC; Hartmann T; Stein R; Grimm MO
Aging Cell; 2014 Apr; 13(2):263-72. PubMed ID: 24304563
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
[TBL] [Abstract][Full Text] [Related]
6. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF
FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
Gong B; Pan Y; Vempati P; Zhao W; Knable L; Ho L; Wang J; Sastre M; Ono K; Sauve AA; Pasinetti GM
Neurobiol Aging; 2013 Jun; 34(6):1581-8. PubMed ID: 23312803
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
10. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
Sheng B; Wang X; Su B; Lee HG; Casadesus G; Perry G; Zhu X
J Neurochem; 2012 Feb; 120(3):419-29. PubMed ID: 22077634
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
Martire S; Fuso A; Mosca L; Forte E; Correani V; Fontana M; Scarpa S; Maras B; d'Erme M
J Alzheimers Dis; 2016 Aug; 54(1):307-24. PubMed ID: 27567805
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of MH84, a γ-secretase modulator with PPARγ agonistic activity.
Pellowska M; Stein C; Pohland M; Merk D; Klein J; Eckert GP; Schubert-Zsilavecz M; Wurglics M
J Pharm Biomed Anal; 2015 Jan; 102():417-24. PubMed ID: 25459941
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
Devi L; Ohno M
Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
[TBL] [Abstract][Full Text] [Related]
16. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
18. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
Kumar S; Reddy AP; Yin X; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
Dixit S; Fessel JP; Harrison FE
Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
[TBL] [Abstract][Full Text] [Related]
20. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
